WebAug 31, 2024 · CStone Pharmaceuticals (HKEX: 2616) is a biopharmaceutical company focused on developing and commercializing innovative immuno-oncology and precision … WebMar 30, 2024 · Suzhou-China based Cstone Pharmaceuticals Co. Ltd., which in-licensed RET inhibitor pralsetinib from Blueprint Medicines Corp. in 2024, has won Chinese approval for the drug to treat adult patients with locally advanced or metastatic RET fusion-positive non-small-cell lung cancer after platinum-based chemotherapy.
CSTONE PHARMACEUTICALS : Shareholders Board Members …
WebAlso Known As 基石药业, Jishi Yaoye. Legal Name CStone Pharmaceuticals Co., Ltd. Stock Symbol HKG:2616. Company Type For Profit. Contact Email … WebDec 3, 2024 · Please contact Sales at: (212) 520-2765 or email [email protected] Latest From CStone Pharmaceuticals (Suzhou) Co., Ltd Asia Deal Watch: Astellas Looks To Next-Gen AAV Vectors Despite Gene Therapy Clinical Setbacks 03 Dec 2024 News By Ian Haydock, Anju Ghangurde, Dexter Yan, … jitterbug touch 2 phone
CStone received IND approval in China for HDAC6 …
WebJan 5, 2024 · CStone Pharmaceuticals is a China-based investment holding company. Through its subsidiaries, the Company is primarily engaged in development, … WebFind company research, competitor information, contact details & financial data for SPI Precision (Suzhou) Co., Ltd. of Suzhou, Jiangsu. Get the latest business insights from Dun & Bradstreet. WebJul 12, 2024 · CStone Pharmaceuticals is a clinical stage biopharmaceutical company devoted to the development of innovative drugs. With a broad pipeline, the company engages in the development of cancer... jitterbug through verizon